JP2024546138A5 - - Google Patents
Info
- Publication number
- JP2024546138A5 JP2024546138A5 JP2024535372A JP2024535372A JP2024546138A5 JP 2024546138 A5 JP2024546138 A5 JP 2024546138A5 JP 2024535372 A JP2024535372 A JP 2024535372A JP 2024535372 A JP2024535372 A JP 2024535372A JP 2024546138 A5 JP2024546138 A5 JP 2024546138A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- zwitterion
- composition according
- hcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163289501P | 2021-12-14 | 2021-12-14 | |
| US63/289,501 | 2021-12-14 | ||
| PCT/CA2022/051797 WO2023108260A1 (en) | 2021-12-14 | 2022-12-08 | Tryptamine prodrugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024546138A JP2024546138A (ja) | 2024-12-17 |
| JP2024546138A5 true JP2024546138A5 (enExample) | 2025-12-24 |
Family
ID=86775179
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024535372A Pending JP2024546138A (ja) | 2021-12-14 | 2022-12-08 | トリプタミンプロドラッグ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250051278A1 (enExample) |
| EP (1) | EP4448489A4 (enExample) |
| JP (1) | JP2024546138A (enExample) |
| CN (1) | CN118679146A (enExample) |
| CA (1) | CA3240633A1 (enExample) |
| WO (1) | WO2023108260A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023168023A1 (en) | 2022-03-04 | 2023-09-07 | Reset Pharmaceuticals, Inc. | Co-crystals or salts comprising psilocin |
| WO2025250900A1 (en) * | 2024-05-30 | 2025-12-04 | Caamtech, Inc. | 4-hydroxy-n,n-diisopropyltryptaminium hydroglutarate |
| WO2026024591A1 (en) * | 2024-07-22 | 2026-01-29 | Reunion Neuroscience, Inc. | Tryptamine prodrug solid forms |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220137081A (ko) * | 2020-02-04 | 2022-10-11 | 마인드셋 파마 인크. | Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 실로신 유도체 |
| CN119285527A (zh) * | 2020-06-30 | 2025-01-10 | 瑞安神经科学公司 | 色胺前药 |
| JP2024500397A (ja) * | 2020-12-18 | 2024-01-09 | コンパス パスファインダー リミテッド | 治療用途のための修飾インドールアルカロイド |
-
2022
- 2022-12-08 US US18/719,620 patent/US20250051278A1/en active Pending
- 2022-12-08 CA CA3240633A patent/CA3240633A1/en active Pending
- 2022-12-08 CN CN202280082458.9A patent/CN118679146A/zh active Pending
- 2022-12-08 JP JP2024535372A patent/JP2024546138A/ja active Pending
- 2022-12-08 WO PCT/CA2022/051797 patent/WO2023108260A1/en not_active Ceased
- 2022-12-08 EP EP22905564.5A patent/EP4448489A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023531311A5 (enExample) | ||
| JP2024546138A5 (enExample) | ||
| JP5253696B2 (ja) | 抗腫瘍作用を有するインドリル−３−グリオキシル酸誘導体 | |
| EP4328224A1 (en) | Parp inhibitor containing piperazine structure, preparation method therefor and pharmaceutical use thereof | |
| CN103249697B (zh) | 适用作多巴胺能稳定剂的普利多匹定(pridopidine)氘化类似物 | |
| JPH01226818A (ja) | アリールアミドアザビシクロアルカン類およびアリールチオアミドアザビシクロアルカン類からなる記憶力増進剤または記憶障害治療剤 | |
| JP2015518891A (ja) | 抗ウイルス化合物の固体形態 | |
| JPH0211579B2 (enExample) | ||
| RU2008116320A (ru) | Выбранные антагонисты cgrp-пептида, способ их получения, а также их применение в качестве лекарственных средств | |
| JOP20240217A1 (ar) | مشتقات الكوينولين كمُعدِّلات للعضو x2 لمستقبل بروتين g مرتبط بـ mas ومنتجات ذات صلة | |
| JP2016512818A (ja) | テトランドリンファミリーの医薬製剤及び方法 | |
| HU197842B (en) | Process for producing pharmaceutical compositions comprising 2-alkoxy-n-(1-azabicyclo/2.2.2/oct-3-yl)-benzamide derivatives | |
| JP2024544698A5 (enExample) | ||
| JP2010533720A (ja) | 不安を処置するための方法 | |
| WO2023104039A1 (zh) | 呋喃核糖基吡啶衍生物及其药物组合物和用途 | |
| TW202104186A (zh) | 多奈派齊肉豆蔻基氧基甲基醚或其之藥理容許鹽 | |
| IL95250A (en) | 1-(pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments | |
| EP0306345A2 (en) | 2-Alkoxy-n-(1-azabicyclo(2.2.2)-oct-3-yl) benzamides and thiobenzamides having an antischizophrenic activity | |
| IE66601B1 (en) | 2,3-Dihydro-1-(pyridinylamino)-indoles a process for their preparation and their use as medicaments | |
| RS59300B1 (sr) | Postupak za tretman hepatičke encefalopatije | |
| JPH0597801A (ja) | インドール誘導体およびこれを有効成分とする抗潰瘍薬 | |
| EP0669911B1 (en) | Indole derivative having prolonged immunostimulating activity and pharmaceutical compositions therefrom | |
| HUP0203790A2 (hu) | (6-Metoxi-2-naftil)-ecetsav prodrugokat tartalmazó gyógyszerkészítmények alkalmazása gyulladás kezelésére | |
| JP2024507550A5 (enExample) | ||
| JPS61502891A (ja) | 新規の免疫に有効な化合物 |